Evidence map›Paper›PMID 33495636›Full record

ArticleNature neuroscience2021

Phagocyte-mediated synapse removal in cortical neuroinflammation is promoted by local calcium accumulation.

Mehrnoosh Jafari, Adrian-Minh Schumacher, Nicolas Snaidero, Emily M Ullrich Gavilanes, Tradite Neziraj, Virág Kocsis-Jutka, Daniel Engels, Tanja Jürgens, Ingrid Wagner, Juan Daniel Flórez Weidinger and 12 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 93 citations in OpenAlex.

  1. Immune-mediated excitotoxicity in brain disorders.Nature reviews. Immunology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. The neuropathobiology of multiple sclerosis.Nature reviews. Neuroscience · 2024
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 3 countries.

Mehrnoosh Jafari *Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany.
Adrian-Minh Schumacher *Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany.
Nicolas Snaidero *Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany.
Emily M Ullrich GavilanesInstitute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany.
Tradite NezirajInstitute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany.
Virág Kocsis-JutkaInstitute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany.
Daniel EngelsInstitute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany.
Tanja JürgensDepartment of Pathology and Immunology, University of Geneva, Geneva, Switzerland.
Ingrid WagnerDepartment of Pathology and Immunology, University of Geneva, Geneva, Switzerland.
Juan Daniel Flórez WeidingerMax Planck Institute for Dynamics and Self-Organization, Göttingen, Germany.
Stephanie S SchmidtInstitute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany.
Eduardo BeltránInstitute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-7266-4098
Nellwyn HaganRare and Neurological Disease Research, Sanofi, Framingham, MA, USA.
Lisa WoodworthRare and Neurological Disease Research, Sanofi, Framingham, MA, USA.
Dimitry OfengeimRare and Neurological Disease Research, Sanofi, Framingham, MA, USA.
Joseph GansTranslational Sciences Genomics, Sanofi, Framingham, MA, USA.
Fred WolfMax Planck Institute for Dynamics and Self-Organization, Göttingen, Germany.
Mario KreutzfeldtDepartment of Pathology and Immunology, University of Geneva, Geneva, Switzerland.ORCID http://orcid.org/0000-0003-0335-2733
Ruben PortuguesSensorimotor Control, Max Planck Institute of Neurobiology, Munich, Germany.ORCID http://orcid.org/0000-0002-1495-9314
Doron MerklerDepartment of Pathology and Immunology, University of Geneva, Geneva, Switzerland. doron.merkler@unige.ch.ORCID http://orcid.org/0000-0002-0247-2007
Thomas MisgeldInstitute of Neuronal Cell Biology, Technical University of Munich, Munich, Germany. thomas.misgeld@tum.de.ORCID http://orcid.org/0000-0001-9875-6794
Martin KerschensteinerInstitute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany. martin.kerschensteiner@med.uni-muenchen.de.ORCID http://orcid.org/0000-0003-4898-9383
Ludwig-Maximilians-Universität München · DEUniversity of Geneva · CHSanofi (United States) · USBernstein Center for Computational Neuroscience Göttingen · DEGerman Center for Neurodegenerative Diseases · DEMunich Cluster for Systems Neurology · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cortical pathology contributes to chronic cognitive impairment of patients suffering from the neuroinflammatory disease multiple sclerosis (MS). How such gray matter inflammation affects neuronal structure and function is not well understood. In the present study, we use functional and structural in vivo imaging in a mouse model of cortical MS to demonstrate that bouts of cortical inflammation disrupt cortical circuit activity coincident with a widespread, but transient, loss of dendritic spines. Spines destined for removal show local calcium accumulations and are subsequently removed by invading macrophages or activated microglia. Targeting phagocyte activation with a new antagonist of the colony-stimulating factor 1 receptor prevents cortical synapse loss. Overall, our study identifies synapse loss as a key pathological feature of inflammatory gray matter lesions that is amenable to immunomodulatory therapy.

Indexed as

AnimalsCalciumCerebral CortexDendritic SpinesDisease Models, AnimalGray MatterInflammationMiceMicrogliaMultiple SclerosisNeuronsPhagocytesSynapsesCalcium

Identifiers

PMID33495636
OpenAlexW3122577496

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.